Identifying risk factors for rt-pa-related intracerebral hemorrhages in patients with acute stroke

Abstract

Chronic migraine (CM) is a common disorder that compromises the quality of life of patients, decreases functionality, is frequently misdiagnosed, and has poor response to treatment even when diagnosed. Rare and randomized controlled studies on chronic migraine have revealed limitations within current therapeutic options. While pharmacologic treatment includes acute and preventive treatment options, it may lead to some adverse effects, which challenge the tolerance of patients. An increased number of studies in recent years have shown that behavioral interventions such as cognitive behavioral therapy (CBT), biofeedback (BFD), relaxation techniques and neurostimulation procedures lead to a significant improvement in the treatment of chronic migraine. For this reason, such treatment options are recommended, especially in persistent cases with poor response to treatment. The treatment of chronic migraine is more challenging compared with episodic migraine (EM), and recent studies suggest that non-pharmacologic approaches and neurostimulation techniques will increase the chance of success in the treatment of chronic migraine.